In an exclusive interview with Rashmi Mabiyan Kaur, Dr. Sandeep Nayar, Principal Director and HOD, Chest and Respiratory Diseases at BLK-Max Super Speciality Hospital, sheds light on the growing burden of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the role of new medications like Bedaquiline and Delamanid, and the urgent need for policy reforms to strengthen India’s TB elimination efforts. Edited excerpts:
